IL121432A - Pyrrolo [3,2-C]azepine-4-one derivatives and pyrrolo [3,4-C]azepine-4-one derivatives their preparation and pharmaceutical compositions containing them - Google Patents

Pyrrolo [3,2-C]azepine-4-one derivatives and pyrrolo [3,4-C]azepine-4-one derivatives their preparation and pharmaceutical compositions containing them

Info

Publication number
IL121432A
IL121432A IL12143296A IL12143296A IL121432A IL 121432 A IL121432 A IL 121432A IL 12143296 A IL12143296 A IL 12143296A IL 12143296 A IL12143296 A IL 12143296A IL 121432 A IL121432 A IL 121432A
Authority
IL
Israel
Prior art keywords
alkyl
chem
group
azepine
pyrrolo
Prior art date
Application number
IL12143296A
Other languages
English (en)
Other versions
IL121432A0 (en
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Publication of IL121432A0 publication Critical patent/IL121432A0/xx
Publication of IL121432A publication Critical patent/IL121432A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL12143296A 1995-12-01 1996-12-02 Pyrrolo [3,2-C]azepine-4-one derivatives and pyrrolo [3,4-C]azepine-4-one derivatives their preparation and pharmaceutical compositions containing them IL121432A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP33571495 1995-12-01
JP4692896 1996-02-09
PCT/JP1996/003522 WO1997020845A1 (en) 1995-12-01 1996-12-02 Pyrroloazepine derivatives

Publications (2)

Publication Number Publication Date
IL121432A0 IL121432A0 (en) 1998-01-04
IL121432A true IL121432A (en) 2000-09-28

Family

ID=26387089

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12143296A IL121432A (en) 1995-12-01 1996-12-02 Pyrrolo [3,2-C]azepine-4-one derivatives and pyrrolo [3,4-C]azepine-4-one derivatives their preparation and pharmaceutical compositions containing them

Country Status (12)

Country Link
US (4) US5962448A (de)
EP (1) EP0807632B1 (de)
JP (1) JP3563076B2 (de)
KR (1) KR19980701788A (de)
AT (1) ATE216388T1 (de)
AU (1) AU719230B2 (de)
CA (1) CA2212092A1 (de)
DE (1) DE69620745T2 (de)
ES (1) ES2179218T3 (de)
HU (1) HUP9900672A3 (de)
IL (1) IL121432A (de)
WO (1) WO1997020845A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962448A (en) 1995-12-01 1999-10-05 Suntory Limited Pyrroloazepine derivatives
JPH10251258A (ja) * 1997-03-14 1998-09-22 Suntory Ltd ピロロアゼピン系化合物
JPH11193290A (ja) 1997-12-26 1999-07-21 Suntory Ltd ピロールスルホンアミド系化合物
JPH11193289A (ja) * 1997-12-26 1999-07-21 Suntory Ltd ピロールスルホンアミド誘導体
DE60011711T2 (de) * 1999-02-17 2005-07-07 Daiichi Suntory Pharma Co., Ltd. Pyrroloazepinderivate enthaltende arzneimittel zur behandlung von claudicatio intermittens
ATE260916T1 (de) * 1999-12-16 2004-03-15 Daiichi Suntory Pharma Co Ltd Verfahren zur herstellung von optisch aktiven pyrroloazepinderivaten
FR3008975A1 (fr) 2013-07-23 2015-01-30 Servier Lab Nouveaux derives de pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ES2919779T3 (es) 2017-06-20 2022-07-28 Imbria Pharmaceuticals Inc Derivado de 1-[(2,3,4-trimetoxifenil)metil]-piperazina, composiciones del mismo y métodos para aumentar la eficiencia del metabolismo cardíaco
MX2021000942A (es) * 2018-07-23 2021-03-31 Sumitomo Pharma Co Ltd Derivado de lactama condensado.
US11530184B2 (en) 2020-06-30 2022-12-20 Imbria Pharmaceuticals, Inc. Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate
US11780811B2 (en) 2020-06-30 2023-10-10 Imbria Pharmaceuticals, Inc. Methods of synthesizing 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate
US11883396B2 (en) 2021-05-03 2024-01-30 Imbria Pharmaceuticals, Inc. Methods of treating kidney conditions using modified forms of trimetazidine
CN113788777B (zh) * 2021-09-07 2023-04-11 华中科技大学 一种制备1-取代-3-羰基吡咯的方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2419119A (en) * 1943-07-02 1947-04-15 Westinghouse Electric Corp Apparatus for treating and storing meat
US2545491A (en) * 1945-10-25 1951-03-20 American Instr Co Inc Apparatus for precision control of climatic conditions
US2825680A (en) * 1953-03-31 1958-03-04 Niagara Blower Co Apparatus for concentrating aqueous solutions of hygroscopic organic substances
US3424231A (en) * 1967-03-23 1969-01-28 Andrew Truhan Environmental chamber
US3415313A (en) * 1967-06-12 1968-12-10 Niagara Blower Co Apparatus for producing air at widely different temperatures and relative humidities
US3671273A (en) * 1968-05-20 1972-06-20 Alec C Gunter Apparatus for preparing a cocoa concentrate
US3617699A (en) * 1969-03-10 1971-11-02 Donald F Othmer A system for electrically heating a fluid being transported in a pipe
US4103508A (en) * 1977-02-04 1978-08-01 Apple Hugh C Method and apparatus for conditioning air
FR2578842B1 (fr) 1985-03-15 1987-04-10 Rhone Poulenc Sante Nouveaux derives de la pyrrolo(1,2-a) azepinone, leur preparation et les compositions pharmaceutiques qui les contiennent
JPS62161786A (ja) * 1986-01-08 1987-07-17 Mitsubishi Chem Ind Ltd ピロ−ル化合物
US4769998A (en) * 1986-04-25 1988-09-13 Advantage Electronics, Incorporated Precision-controlled water chiller
DK170506B1 (da) * 1987-09-03 1995-10-02 Glaxo Group Ltd Pyrido- og azepino-indolforbindelser, fremgangsmåde til fremstilling deraf, farmaceutisk præparat indeholdende dem samt anvendelse af forbindelserne
ES2088389T3 (es) * 1988-08-02 1996-08-16 Glaxo Group Ltd Derivados de lactamas.
JP3198117B2 (ja) * 1990-02-07 2001-08-13 サントリー株式会社 ピロロアゼピン誘導体
JPH0525128A (ja) * 1990-05-11 1993-02-02 Suntory Ltd ピロロアゼピン誘導体の製造方法
WO1993003032A1 (en) * 1991-08-07 1993-02-18 Suntory Limited Pyrroloazepine compound
KR100243514B1 (ko) * 1991-08-07 2000-03-02 도리이 신이치로 피롤로아제핀 유도체
US5544275A (en) * 1993-03-17 1996-08-06 Applied Materials, Inc. Electrically heated fluid carrying conduit having integrated heating elements and electrical conductors
JP3714685B2 (ja) * 1994-05-18 2005-11-09 第一サントリーファーマ株式会社 ハイメニアルディシン及びその誘導体並びにそれらの合成中間体の製造法並びにその合成中間体
CA2189297C (en) * 1995-11-02 2004-09-21 Masahiro Imoto Process for preparing 1-substituted pyrrole-3-carboxylic acid derivatives
US5962448A (en) 1995-12-01 1999-10-05 Suntory Limited Pyrroloazepine derivatives
JPH10251258A (ja) 1997-03-14 1998-09-22 Suntory Ltd ピロロアゼピン系化合物
JPH11193289A (ja) 1997-12-26 1999-07-21 Suntory Ltd ピロールスルホンアミド誘導体

Also Published As

Publication number Publication date
DE69620745T2 (de) 2002-10-31
US6489473B2 (en) 2002-12-03
JP3563076B2 (ja) 2004-09-08
US20020072515A1 (en) 2002-06-13
US6713634B2 (en) 2004-03-30
US5962448A (en) 1999-10-05
AU7655896A (en) 1997-06-27
EP0807632A1 (de) 1997-11-19
DE69620745D1 (de) 2002-05-23
KR19980701788A (ko) 1998-06-25
HUP9900672A3 (en) 2001-11-28
AU719230B2 (en) 2000-05-04
ES2179218T3 (es) 2003-01-16
ATE216388T1 (de) 2002-05-15
CA2212092A1 (en) 1997-06-12
IL121432A0 (en) 1998-01-04
EP0807632A4 (de) 1998-12-09
US20030166926A1 (en) 2003-09-04
EP0807632B1 (de) 2002-04-17
US6258805B1 (en) 2001-07-10
HUP9900672A2 (hu) 1999-06-28
WO1997020845A1 (en) 1997-06-12

Similar Documents

Publication Publication Date Title
IL121432A (en) Pyrrolo [3,2-C]azepine-4-one derivatives and pyrrolo [3,4-C]azepine-4-one derivatives their preparation and pharmaceutical compositions containing them
HUT70035A (en) Condensed imidazo pyridine derivatives, pharmaceutical preparations containing them and process for their preparation
AU2344988A (en) Piperidine-tetra hydrofurane or tetra hydrothiophene spiro derivatives and methods for their preparation
AU8345491A (en) Heterocyclic derivatives
NO990227L (no) Heterocykliske forbindelser som farmas°ytika
IL93816A0 (en) Acryloyl substituted pyrrole derivatives,their preparation and pharmaceutical compositions containing them
ES2063452T3 (es) Preparacion y uso de esteres y derivados de n-yodopropargil oxicarbonil aminoacido como agentes antimicrobianos.
WO1994019343A3 (en) Novel use as anti-inflammatory agents for bis-heterocyclic compounds and pharmaceutical compositions thereof
DE69129165D1 (de) Prozess zur Darstellung von Lactamderivaten
PE25998A1 (es) DERIVADOS DE OCTAHIDRO-PIRROLO(1,2-a)-PIRAZINA 2,7-SUSTITUIDOS
GR3025599T3 (en) the same Carbazolone derivatives and process for preparing
WO1999033840A3 (en) Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha1-blocking action
HU895422D0 (en) Process for the preparation of 1,4-diazabicyclo [3.2.2] nonane derivatives
ATE86866T1 (de) Antikrebs-zusammensetzung.
KR920004392A (ko) 플루오로에틸캄프토테신 유도체
AU7529287A (en) Pristinamycin process
CA2093631A1 (en) Pyrroloazepine derivative
NO982282L (no) Synergistisk immunsuppresjonspreparat inneholdende en 2,2'-bi-1H-pyrrolforbindelse
CA2168514A1 (en) Isocarbacyclin derivatives
DE68922053D1 (de) Pyridoindolderivate und Verfahren zu ihrer Herstellung.
ES8705413A1 (es) Un procedimiento para preparar derivados de benzopirano.
CA2053705A1 (en) Piperazine derivatives
ES2087173T3 (es) Uso de derivados de piridoindol en el tratamiento de enfermedades isquemicas.
EP1352906A4 (de) Zusammensetzungen für die prävention bzw. behandlung von lebererkrankungen
EP0294828A3 (en) Mitomycin analogs, a process for preparing them and pharmaceutical compositions

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
HP Change in proprietorship
MM9K Patent not in force due to non-payment of renewal fees